College Hill - international business communications consultancy

College Hill is a growing international business communications consultancy with offices in Europe, China, India, South Africa and the United States. College Hill's wide range of complementar...

macitentan

Macitentan (Opsumit®) is a novel dual endothelin receptor antagonist (ERA) that resulted from a tailored drug discovery process with the target to develop an ERA optimized for efficacy and safet...

Colorado

Colorado is a state in the south-west of the US, in the Southern Rocky Mountains. It is home to a fast growing and exciting biotechnology industry. The Colorado BioScience Association founded in 200...

Orphan Diseases

The European Organization for Rare Diseases considers orphan diseases to be those that are rare (occur in 1 in 1500 to 1 in 2500 patients, according to US Rare Disease Act 2002 and European Commissi...

ATX-MS-1467 for patients with multiple sclerosis (MS)

ATX-MS-1467 is a novel treatment that was developed with the aim of working with the immune system to treat the underlying cause of disease rather than just treating the symptoms or suppressing the...

New Eppendorf Advantage™ promotion delivers up to 20% savings

Valid until 30 June 2013, Eppendorf’s latest Advantage promotion delivers considerable savings on a variety of product bundles, offering researchers the chance to try products from this leading...

Eppendorf celebrates opening of new UK headquarters

Eppendorf has celebrated the opening of its new UK headquarters in Stevenage together with 60 guests from all walks of science and industry. Guest of honour Dr Dirk Ehlers, President & CEO of Eppendor...

Eppendorf Young Investigator Award 2012 goes to the United Kingdom

The 2012 Eppendorf Award is the 17th research prize conferred by the Hamburg life science company. This year it was presented to Elizabeth Murchison, Ph.D. (Wellcome Trust Sanger Institute, Hinxton, C...

Eppendorf Announces New Brunswick CelliGen® BLU cabinet / 50L CelliGen® BLU vessel

Eppendorf is proud to announce the release of the next generation New Brunswick CelliGen® BLU cabinet and the much anticipated 50L CelliGen® BLU single-use vessel. The New Bruns...

Singapore GDP grew more than expected in Q4

* Q4 GDP +3.3 pct q/q vs median forecast of +2.1 pct * Q4 GDP +1.5 pct y/y vs median forecast of +1.2 pct * Full-year 2012 GDP +1.3 percent * Singapore reiterates 2013 growth forecast of 1...

Eli Lilly Raises 2012 Net Profit Forecast

Eli Lilly on Thursday raised its net profit forecast for 2012 to reflect income from the early payment of financial obligations from former partner Amylin Pharmaceuticals, which has been acquired by B...

Eppendorf, Vela Develop Nucleic Acid Extraction Platform

CORRECTED-TABLE-Chugai Pharm -9-MTH group results

(Corrects figure for sales forecast to 418.50 billion yen, not 418.00 billion yen) OCTOBER 23 (Reuters)- Chugai Pharmaceutical Co Ltd CONSOLIDATED FINANCIAL HIGHLIGHTS...

Gloomy forecast for the prophets of apocalypse and bright forecast for chemists.

Dimitrios Stavrou : 19 December 1935 to 6 May 2012.

Oncological nonsurgical treatment concepts for head and neck tumors : Highlights from the 2012 ASCO annual meeting.

In vitro and in vivo proof of tolerance after two-step haploidentical bone marrow and kidney transplantation of the same donor.

Does Your Heart Forecast help practitioner understanding and confidence with cardiovascular disease risk communication?

Explaining what cardiovascular disease (CVD) risk means and engaging in shared decision-making regarding risk factor modification is challenging. An electronic CVD risk visualisation tool containing m...